Katsuaki Maehara: The changes in TME and TKI treatment resistance by EGFR and ALK TKI

Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X:             .

“A valuable paper that reveals the changes in tumor microenvironment (TME) and Tyrosine Kinase Inhibitor (TKI) treatment resistance by EGFR and ALK TKI, and studies on overcoming resistance with adjuvant therapies such as aspirin.”

Proceed to the paper.
Source: Katsuaki Maehara/X